Larvol Delta - Viracta-Therapeutics-Announces-Orphan-Drug-Designation-Granted-by-FDA-for-its-AllOral-Combination-of-Nanatinostat-and-Valganciclovir-Nanaval-for-the-Treatment-of-Epstein-Barr-VirusPositive-Diffuse-Large-Bcell-Lymphoma

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-orphan-drug-designation-granted-by-fda-for-its-all-oral-combination-of-nanatinostat-and-valganciclovir-nana-val-for-the-treatment-of-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-301432840.html

Nov 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next